Ponduri Anusha, Liao David Z, Schlecht Nicolas F, Rosenblatt Gregory, Prystowsky Michael B, Kabarriti Rafi, Garg Madhur, Ow Thomas J, Schiff Bradley A, Smith Richard V, Mehta Vikas
1Albert Einstein College of Medicine, Bronx.
2Department of Pathology, and.
J Natl Compr Canc Netw. 2021 Sep 22:1-7. doi: 10.6004/jnccn.2021.7007.
Nonadherence to NCCN Guidelines during time from surgery to postoperative radiotherapy (S-PORT) can alter survival outcomes in head and neck squamous cell carcinomna (HNSCC). There is a need to validate this impact in an underserved urban population and to understand risk factors and reasons for delay. We sought to investigate the impact of delayed PORT with outcomes of overall survival (OS) in HNSCC, to analyze predictive factors of delayed PORT, and to identify reasons for delay.
We conducted a retrospective cohort study in an urban, community-based academic center. A total of 184 patients with primary HNSCC were identified through the Montefiore Medical Center cancer registry who had been treated between March 1, 2005, and March 8, 2017, and met the inclusion and exclusion criteria. The primary exposure was S-PORT. OS, recurrence, and risk factors and reasons for treatment delay were the main outcomes and measures.
Among 184 patients with HNSCC treated with PORT, the median S-PORT was 48.5 days (interquartile range, 41-67 days). The S-PORT threshold that optimally differentiated worse OS outcomes was >50 days (46.7% of our cohort; n=86). Independent of other relevant factors, patients with HNSCC and S-PORT >50 days had worse OS (hazard ratio, 2.30; 95% CI, 1.34-3.95) and greater recurrence (odds ratio, 3.51; 95% CI, 1.31-9.39). Predictors of delayed S-PORT included being underweight or obese, prolonged postoperative length of stay, and age >70 years. The most frequent reasons for PORT delay were complications related to surgery (22.09%), unrelated medical comorbidities (18.60%), and nonadherence/missed appointments (6.98%).
Delayed PORT beyond 50 days after surgery was associated with decreased OS and greater recurrence. Identification of predictive factors and reasons for treatment delay helps to target at-risk patients and facilitates interventions in underserved populations.
从手术到术后放疗(S-PORT)期间不遵循美国国立综合癌症网络(NCCN)指南会改变头颈部鳞状细胞癌(HNSCC)的生存结局。有必要在服务不足的城市人群中验证这种影响,并了解延迟的风险因素和原因。我们试图研究延迟PORT对HNSCC总生存(OS)结局的影响,分析延迟PORT的预测因素,并确定延迟的原因。
我们在一个以社区为基础的城市学术中心进行了一项回顾性队列研究。通过蒙特菲奥里医疗中心癌症登记处确定了2005年3月1日至2017年3月8日期间接受治疗且符合纳入和排除标准的184例原发性HNSCC患者。主要暴露因素是S-PORT。OS、复发以及治疗延迟的风险因素和原因是主要结局和测量指标。
在184例接受PORT治疗的HNSCC患者中,S-PORT的中位数为48.5天(四分位间距,41 - 67天)。最佳区分较差OS结局的S-PORT阈值>50天(我们队列中的46.7%;n = 86)。独立于其他相关因素,S-PORT>50天的HNSCC患者OS较差(风险比,2.30;95%CI,1.34 - 3.95)且复发率更高(比值比,3.51;95%CI,1.31 - 9.39)。延迟S-PORT的预测因素包括体重过轻或肥胖、术后住院时间延长以及年龄>70岁。PORT延迟最常见的原因是与手术相关的并发症(22.09%)、无关的内科合并症(18.60%)以及不依从/错过预约(6.98%)。
术后超过50天延迟PORT与OS降低和复发率增加相关。识别预测因素和治疗延迟的原因有助于针对高危患者,并促进对服务不足人群的干预。